Related Experiment Video
Updated: Oct 26, 2025

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Investigating the sequence variation in the influenza A matrix genes during the 2017-2018 and 2018-2019 seasons in
James Finch1, Mark Zuckerman1, Melvyn Smith1
1Viapath Analytics, South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, United Kingdom.
Abstract:
Recent publications have highlighted the emergence of mutations in the M1 gene of both influenza A H1N1pdm09 and H3N2 subtypes affecting the performance of commercial RT-PCR assays. Respiratory samples from the 2018/2019 season positive by our in-house RT-PCR for influenza A were analysed for the prevalence and impact of any M1 gene mutations. Sequence information was used to re-design primers for our routine assay and their performance assessed. Forty-five samples, consisting of 11 H1N1pdm09 and 34 H3N2 subtypes, together with the NIBSC H1N1 control were sequenced. All samples displayed the core mutations for H1N1 M1(C154T; G174A and G238A) and for H3N2 M1(C153T; C163T and G189T); three of the H1N1pdm09 viruses also showed a small number of point mutations. None of the mutations appeared to affect either the sensitivity or efficiency of the RT-PCR when compared to the re-designed primers. Although the mutations we found agreed with those in the publications cited we did not encounter any problems with our routine diagnostic assay and no improvements were found when the primers were modified to suit those mutations. However, it is likely that the influenza A virus M1 gene will accumulate further mutations that could impact RT-PCR assays and, therefore, it would be prudent to implement routine sequencing of samples during the influenza seasons to ensure no loss in assay performance.
Insights
Mutations in the influenza A virus M1 gene did not impact current RT-PCR diagnostic assay performance. Routine sequencing is recommended to monitor future changes and ensure assay reliability.
Area of Science:
- Virology
- Molecular Biology
- Diagnostic Assays
Background:
- Emerging mutations in the M1 gene of influenza A (H1N1pdm09 and H3N2) can affect RT-PCR assay performance.
- Previous studies indicated potential impacts on diagnostic sensitivity and efficiency.
Purpose of the Study:
- To investigate the prevalence and impact of M1 gene mutations on influenza A RT-PCR assays.
- To re-design primers and assess their performance against identified mutations.
Main Methods:
- Respiratory samples from the 2018/2019 season were analyzed using in-house RT-PCR.
- Sequencing of the M1 gene for H1N1pdm09 and H3N2 subtypes.
- Performance assessment of original and re-designed RT-PCR primers.
Main Results:
- All sequenced samples (11 H1N1pdm09, 34 H3N2) showed characteristic M1 gene mutations.
- No significant impact on RT-PCR sensitivity or efficiency was observed with existing mutations.
- Re-designed primers did not show improved performance compared to the routine assay.
Conclusions:
- Identified M1 gene mutations in influenza A subtypes did not compromise the current RT-PCR diagnostic assay.
- Continuous monitoring through routine sequencing is crucial to detect future mutations that may affect assay performance.
- Proactive surveillance ensures the sustained accuracy of influenza A diagnostics.
Related Concept Videos
Viral Mutations
Viral Recombination
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs
Genetic Variation
Genes exist in different versions called alleles,...

